Congo vs Dominican Republic: Treatment coverage for lymphatic filariasis
Congo
82.1%
in 2024
Dominican Republic
81.7%
in 2017
Congo rank
12th
Dominican Republic rank
14th
Treatment coverage for lymphatic filariasis over time
- Congo
- Dominican Republic
How they compare
Congo currently reports 82.1% against 81.7% in Dominican Republic, a difference of 0.4%.
The two have swapped places 3 times across 5 shared years of data; in 2013 it was Congo ahead.
Congo ranks 12th and Dominican Republic ranks 14th of 66 countries.
Dominican Republic has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Congo or Dominican Republic?
- Congo, at 82.1% against 81.7% in Dominican Republic as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Congo and Dominican Republic?
- 0.4%, with Congo ahead.
- How many years of comparable data are there for Congo and Dominican Republic?
- 5 years are reported by both, from 2013 to 2017.
- How do Congo and Dominican Republic rank globally for treatment coverage for lymphatic filariasis?
- Congo ranks 12th and Dominican Republic ranks 14th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.